Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Rogawski

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Advances in Neurology|December 31, 1997
Mechanism-specific pathways for new antiepileptic drug discoveryM A Rogawski
Archives of Neurology|January 1, 1984
Transdermal scopolamine and sialorrheaM A Rogawski
Trends in Neurosciences|August 15, 2000
KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapyM A Rogawski
Journal of Neurophysiology|August 1, 1986
Single voltage-dependent potassium channels in cultured rat hippocampal neuronsM A Rogawski
Acta Neurologica Scandinavica. Supplementum|March 14, 2013
AMPA receptors as a molecular target in epilepsy therapyM A Rogawski
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 1, 1988
Transient outward current (IA) in clonal anterior pituitary cells: blockade by aminopyridine analogsM A Rogawski
Molecular Pharmacology|April 1, 1989
Aminopyridines enhance opening of calcium-activated potassium channels in GH3 anterior pituitary cellsM A Rogawski
Amino Acids|October 12, 2000
Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents--toward an understanding of their favorable tolerabilityM A Rogawski
British Journal of Pharmacology|June 17, 2008
Brivaracetam: a rational drug discovery success storyM A Rogawski
Drugs|September 1, 1992
The NMDA receptor, NMDA antagonists and epilepsy therapy. A status reportM A Rogawski
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Advances in Neurology|December 31, 1997
Mechanism-specific pathways for new antiepileptic drug discoveryM A Rogawski
Archives of Neurology|January 1, 1984
Transdermal scopolamine and sialorrheaM A Rogawski
Trends in Neurosciences|August 15, 2000
KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapyM A Rogawski
Journal of Neurophysiology|August 1, 1986
Single voltage-dependent potassium channels in cultured rat hippocampal neuronsM A Rogawski
Acta Neurologica Scandinavica. Supplementum|March 14, 2013
AMPA receptors as a molecular target in epilepsy therapyM A Rogawski
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 1, 1988
Transient outward current (IA) in clonal anterior pituitary cells: blockade by aminopyridine analogsM A Rogawski
Molecular Pharmacology|April 1, 1989
Aminopyridines enhance opening of calcium-activated potassium channels in GH3 anterior pituitary cellsM A Rogawski
Amino Acids|October 12, 2000
Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents--toward an understanding of their favorable tolerabilityM A Rogawski
British Journal of Pharmacology|June 17, 2008
Brivaracetam: a rational drug discovery success storyM A Rogawski
Drugs|September 1, 1992
The NMDA receptor, NMDA antagonists and epilepsy therapy. A status reportM A Rogawski
Pageof 12